4.8 Article

Pbrm1 Steers Mesenchymal Stromal Cell Osteolineage Differentiation by Integrating PBAF-Dependent Chromatin Remodeling and BMP/TGF-β Signaling

期刊

CELL REPORTS
卷 31, 期 4, 页码 -

出版社

CELL PRESS
DOI: 10.1016/j.celrep.2020.107570

关键词

-

资金

  1. Council for Scientific & Industrial Research (CSIR) [ESC 0103]
  2. Department of Biotechnology (DBT) [BT/RLF/RE-ENTRY/06/2010]
  3. DBT [BT/PR13023/MED/31/311/2015]
  4. Department of Science & Technology (DST), Govt. of India [SB/SO/HS-053/2013]
  5. Indian Council of Medical Research (ICMR)-DHR International Fellowship [INDO/FRC/452/S-11/2019-20-lHD]
  6. CSIR
  7. UGC
  8. Council for Scientific & Industrial Research (CSIR) (NWP/BIOCERAM)

向作者/读者索取更多资源

Bone morphogenic protein (BMP)/transforming growth factor beta (TGF-beta) signaling determines mesenchymal-stromal-cell (MSC) osteolineage commitment and tissue identity. However, molecular integration of developmental signaling with MSC-intrinsic chromatin regulation remains incompletely understood. SWI/SNF-(BAF) is an ATP-dependent chromatin remodeler implicated in multi-cellular development. We show that BMPs and long-term osteogenic signals in MSCs selectively induce expression of polybromo BAF (PBAF) components Pbrm1, Arid2, and Brd7. Loss of Pbrm1/Arid2/Brd7 profoundly impairs osteolineage gene expression and osteogenesis without compromising adipogenesis. Pbrm1 loss attenuates MSC in vivo ossification. Mechanistically, Pbrm1/PBAF deficiency impairs Smad1/5/8 activation through locus-specific epi-genomic remodeling, involving Pbrm1 bromodomains, along with transcriptional downregulation of Bmpr/Tgf beta rII affecting BMP-early-responsive gene expression. Gain of function of BmprI beta, Tgf beta rII in PBAF-deficient MSCs partly restores Smad1/5/8 activation and osteogenesis. Pbrm1 loss further affects hematopoietic stem and progenitor activity through non-cell-autonomous regulation of microenvironment and niche-factor expression. Together, these findings reveal a link illustrating epi-genomic feedforward control of BMP/TGF-beta signaling to transcriptional and cellular plasticity in the mesenchymal microenvironment and account for stromal SWI/SNF in hematopoiesis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Hematology

SWI/SNF subunit expression heterogeneity in human aplastic anemia stem/progenitors

Sayantani Sinha, Shankha Subhra Chatterjee, Mayukh Biswas, Arijit Nag, Debasis Banerjee, Rajib De, Amitava Sengupta

EXPERIMENTAL HEMATOLOGY (2018)

Article Oncology

SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia

Shankha Subhra Chatterjee, Mayukh Biswas, Liberalis Debraj Boila, Debasis Banerjee, Amitava Sengupta

MOLECULAR CANCER RESEARCH (2018)

Article Biochemistry & Molecular Biology

MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia

Mayukh Biswas, Shankha Subhra Chatterjee, Liberalis Debraj Boila, Sayan Chakraborty, Debasis Banerjee, Amitava Sengupta

FASEB JOURNAL (2019)

Article Oncology

Transcriptomic Analysis Identifies RNA Binding Proteins as Putative Regulators of Myelopoiesis and Leukemia

Subha Saha, Krushna Chandra Murmu, Mayukh Biswas, Sohini Chakraborty, Jhinuk Basu, Swati Madhulika, Srinivasa Prasad Kolapalli, Santosh Chauhan, Amitava Sengupta, Punit Prasad

FRONTIERS IN ONCOLOGY (2019)

Review Biochemistry & Molecular Biology

Emerging trends in chromatin remodeler plasticity in mesenchymal stromal cell function

Sayan Chakraborty, Sayantani Sinha, Amitava Sengupta

Summary: The integration of epigenetic regulation with transcriptional and cell signaling machinery plays a crucial role in determining tissue resident adult pluripotent mesenchymal stem/stromal cell (MSC) activity, lineage commitment, and immunomodulation. Histone modifying enzymes and chromatin remodeling complexes are central features influencing gene regulation and tissue identity establishment in MSCs. Modulation of transcription factor expression gradient and flexibility of chromatin architecture are exciting approaches to regulate MSC activity.

FASEB JOURNAL (2021)

Article Hematology

Functional mapping of PHF6 complexes in chromatin remodeling, replication dynamics, and DNA repair

Silvia Alvarez, Ana C. da Silva Almeida, Robert Albero, Mayukh Biswas, Angelica Barreto-Galvez, Thomas S. Gunning, Anam Shaikh, Tomas Aparicio, Agnieszka Wendorff, Erich Piovan, Pieter Van Vlierberghe, Steven Gygi, Jean Gautier, Advaitha Madireddy, Adolfo A. Ferrando

Summary: Research has shown that the PHF6 gene is involved in multiple molecular mechanisms, including nucleosome remodeling and DNA repair. After DNA damage, PHF6 localizes to the sites of injury and its absence impairs the resolution of DNA breaks. Furthermore, PHF6 specifically associates with difficult-to-replicate heterochromatin, making it an important regulator of genomic stability.
Meeting Abstract Hematology

Therapeutic Targeting of Spliceosome Mutant Myeloid Neoplasms Via PARP1 Inhibition

Sayantani Sinha, Zhiyan Silvia Liu, Maxwell Bannister, Erica Arriaga-Gomez, Axia Song, Dawei Zong, Martina Sarchi, Elizabeth Bonner, Victor Corral, Cassandra Leibson, Wannasiri Chiraphapphaiboon, Derek Stirewalt, Joachim Deeg, Sumit Rai, Matthew J. Walter, Timothy A. Graubert, Sergei Doulatov, Dang Hai Nguyen, Stanley Chun-Wei Lee

Article Oncology

KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition

Liberalis Debraj Boila, Subhadeep Ghosh, Subham K. Bandyopadhyay, Liqing Jin, Alex Murison, Andy G. X. Zeng, Wasim Shaikh, Satyaki Bhowmik, Siva Sai Naga Anurag Muddineni, Mayukh Biswas, Sayantani Sinha, Shankha Subhra Chatterjee, Nathan Mbong, Olga I. Gan, Anwesha Bose, Sayan Chakraborty, Andrea Arruda, James A. Kennedy, Amanda Mitchell, Eric R. Lechman, Debasis Banerjee, Michael Milyavsky, Mark D. Minden, John E. Dick, Amitava Sengupta

Summary: Acute myeloid leukemia (AML) is a heterogeneous and aggressive malignancy with limited targeted therapies. This study found that KDM6-demethylase function critically regulates DNA-damage-repair-(DDR) gene expression in AML. KDM6A loss-of-function mutations are linked to chemoresistance, while upregulated KDM6A is associated with venetoclax tolerance. Combination therapy targeting PARP and BCL2 was shown to be superior in inducing AML apoptosis, particularly in AML cells carrying KDM6A-domain mutations. Therefore, KDM6A could be a potential molecular regulator for determining therapeutic efficacy in AML.

LEUKEMIA (2023)

Article Biochemical Research Methods

Establishment of a Long-Term Co-culture Assay for Mesenchymal Stromal Cells and Hematopoietic Stem/Progenitors

Sayantani Sinha, Sayan Chakraborty, Amitava Sengupta

STAR PROTOCOLS (2020)

暂无数据